Vorapaxar(free base)
Catalog No: 16070916
CAS Number: 618385-01-6
Purity: 98% by HPLC
Vorapaxar, also known as SCH 530348, is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine. Discovered by Schering-Plough and currently being developed by Merck & Co., it is an experimental pharmaceutical treatment for acute coronary syndrome chest pain caused by coronary artery disease. On May 05, 2014, vorapaxar obtained FDA approval.
For research use only. We do not sell to patients.
Chemical Information
| Name | Vorapaxar(free base) |
|---|---|
| Iupac Chemical Name | Ethyl N-[(3R,3aS,4S,4aR,7R,8aR,9aR)-4-[(E)-2-[5-(3-fluorophenyl)-2-pyridyl]vinyl]-3-methyl-1-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3H-benzo[f]isobenzofuran-7-yl]carbamate |
| Synonyms | SCH530348;SCH 530348, |
| Molecular Formula | C29H35FN2O8S |
| Molecular Weight | 590.6634 |
| Smile | FC=1C=C(C=CC1)C=1C=CC(=NC1)/C=C/[C@H]1[C@H]2[C@H](C[C@H]3C(O[C@@H]([C@@H]13)C)=O)C[C@@H](CC2)NC(OCC)=O |
| InChiKey | ZBGXUVOIWDMMJE-QHNZEKIYSA-N |
| InChi | InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1 |
| CAS Number | 618385-01-6 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% by HPLC |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
-cas-618385-01-6.png)